Keywords: ec, clears, gsk, arixtra, prevention, vte, uk

EC clears GSK's Arixtra for prevention of VTE

Article | 14 February 2005

Print This

UK drug major GlaxoSmithKline says that the European Commission has approved the use of Arixtra (fondaparinux sodium) for the prevention ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in